ADMA vs. DRX.TO
ADMA (ADMA Biologics, Inc.) and DRX.TO (ADF Group Inc.) are both stocks. ADMA operates in Biotechnology (Healthcare), while DRX.TO operates in Metal Fabrication (Industrials). Over the past 10 years, ADMA returned 1.08%/yr vs 12.50%/yr for DRX.TO. At a 0.06 correlation, their price movements are largely independent.
Performance
ADMA vs. DRX.TO - Performance Comparison
Loading charts...
Different Trading Currencies
ADMA is traded in USD, while DRX.TO is traded in CAD. To make them comparable, the DRX.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, ADMA achieves a -55.81% return, which is significantly lower than DRX.TO's 9.95% return. Over the past 10 years, ADMA has underperformed DRX.TO with an annualized return of 1.08%, while DRX.TO has yielded a comparatively higher 12.50% annualized return.
ADMA
- 1D
- 1.13%
- 1M
- -1.35%
- YTD
- -55.81%
- 6M
- -58.43%
- 1Y
- -60.89%
- 3Y*
- 28.26%
- 5Y*
- 34.37%
- 10Y*
- 1.08%
DRX.TO
- 1D
- -3.74%
- 1M
- -4.09%
- YTD
- 9.95%
- 6M
- 34.43%
- 1Y
- 51.22%
- 3Y*
- 41.16%
- 5Y*
- 40.17%
- 10Y*
- 12.50%
ADMA vs. DRX.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | -55.81% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
DRX.TO ADF Group Inc. | 9.95% | -0.33% | 30.09% | 239.85% | 24.09% | 9.48% | 19.76% | 33.93% | -55.29% | -19.89% |
Correlation
The correlation between ADMA and DRX.TO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013 | 0.06 |
Fundamentals
ADMA:
$1.93B
DRX.TO:
CA$169.54M
ADMA:
$0.68
DRX.TO:
CA$1.07
ADMA:
11.91
DRX.TO:
9.59
ADMA:
3.86
DRX.TO:
0.98
ADMA:
4.95
DRX.TO:
0.92
ADMA:
$509.86M
DRX.TO:
CA$258.74M
ADMA:
$312.42M
DRX.TO:
CA$59.38M
ADMA:
$218.74M
DRX.TO:
CA$43.53M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ADMA vs. DRX.TO — Risk / Return Rank
ADMA
DRX.TO
ADMA vs. DRX.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and ADF Group Inc. (DRX.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ADMA | DRX.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.89 | ||
| Sortino ratioReturn per unit of downside risk | -3.66 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.22 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.94 | 1.50 | -2.44 |
| Martin ratioReturn relative to average drawdown | -1.81 | 2.89 | -4.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ADMA | DRX.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.12 | 0.77 | -1.89 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.58 | 0.69 | -0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.02 | 0.22 | -0.20 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.01 | 0.17 | -0.18 |
Drawdowns
ADMA vs. DRX.TO - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, roughly equal to the maximum DRX.TO drawdown of -94.08%. Use the drawdown chart below to compare losses from any high point for ADMA and DRX.TO.
Loading charts...
Drawdown Indicators
| ADMA | DRX.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.28% | -94.08% | +2.80% |
Max Drawdown (1Y)Largest decline over 1 year | -65.25% | -34.27% | -30.98% |
Max Drawdown (3Y)Largest decline over 3 years | -68.99% | -75.11% | +6.12% |
Max Drawdown (5Y)Largest decline over 5 years | -68.99% | -75.11% | +6.12% |
Max Drawdown (10Y)Largest decline over 10 years | -86.11% | -84.01% | -2.10% |
Current DrawdownCurrent decline from peak | -67.12% | -49.98% | -17.14% |
Average DrawdownAverage peak-to-trough decline | -53.05% | -65.62% | +12.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.62% | 17.75% | +15.87% |
Volatility
ADMA vs. DRX.TO - Volatility Comparison
The current volatility for ADMA Biologics, Inc. (ADMA) is 11.89%, while ADF Group Inc. (DRX.TO) has a volatility of 13.38%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than DRX.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ADMA | DRX.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.89% | 13.38% | -1.49% |
Volatility (6M)Calculated over the trailing 6-month period | 45.36% | 40.86% | +4.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.73% | 66.56% | -11.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.46% | 58.98% | +0.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 69.05% | 57.25% | +11.80% |
Dividends
ADMA vs. DRX.TO - Dividend Comparison
ADMA has not paid dividends to shareholders, while DRX.TO's dividend yield for the trailing twelve months is around 0.39%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DRX.TO ADF Group Inc. | 0.39% | 0.43% | 0.31% | 0.29% | 0.95% | 1.24% | 1.34% | 1.54% | 1.94% | 0.93% | 0.69% | 0.68% |
Financials
ADMA vs. DRX.TO - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and ADF Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ADMA vs. DRX.TO - Profitability Comparison
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
DRX.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADF Group Inc. reported a gross profit of 16.93M and revenue of 78.79M. Therefore, the gross margin over that period was 21.5%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
DRX.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADF Group Inc. reported an operating income of 9.02M and revenue of 78.79M, resulting in an operating margin of 11.5%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
DRX.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADF Group Inc. reported a net income of 6.36M and revenue of 78.79M, resulting in a net margin of 8.1%.
Frequently Asked Questions
ADMA and DRX.TO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for ADMA and DRX.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer